WHO hepatitis C elimination targets: the global equity challenge

被引：19

作者：

Heath, Katherine ^{[1
]}

Hill, Andrew ^{[2
]}

机构：

[1] Burnet Inst, Melbourne, Vic 3004, Australia

[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool, England

来源：

LANCET GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 9卷 / 04期

关键词：

D O I：

10.1016/S2468-1253(23)00408-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：286 / 288

页数：3

共 13 条

[1]

Australian Governement: Department of Health and Aged Care, 2023, General statement for drugs for the treatment of hepatitis C

[2] Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries [J].

Barber, Melissa J. ;

Gotham, Dzintars ;

Khwairakpam, Giten ;

Hill, Andrew .

JOURNAL OF VIRUS ERADICATION, 2020, 6 (03)

[3]

Blach S., 2022, American Association for the Study of Liver Diseases

[4] Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study [J].

Blach, Sarah ;

Terrault, Norah A. ;

Tacke, Frank ;

Gamkrelidze, Ivane ;

Craxi, Antonio ;

Tanaka, Junko ;

Waked, Imam ;

Dore, Gregory J. ;

Abbas, Zaigham ;

Abdallah, Ayat R. ;

Abdulla, Maheeba ;

Aghemo, Alessio ;

Aho, Inka ;

Akarca, Ulus S. ;

Alalwan, Abduljaleel M. ;

Blome, Marianne Alanko ;

Al-Busafi, Said A. ;

Aleman, Soo ;

Alghamdi, Abdullah S. ;

Al-Hamoudi, Waleed K. ;

Aljumah, Abdulrahman A. ;

Al-Naamani, Khalid ;

Al Serkal, Yousif M. ;

Altraif, Ibrahim H. ;

Anand, Anil C. ;

Anderson, Motswedi ;

Andersson, Monique, I ;

Athanasakis, Kostas ;

Baatarkhuu, Oidov ;

Bakieva, Shokhista R. ;

Ben-Ari, Ziv ;

Bessone, Fernando ;

Biondi, Mia J. ;

Bizri, Abdul Rahman N. ;

Mello, Carlos E. Brandaoo ;

Brigida, Krestina ;

Brown, Kimberly A. ;

Brown, Robert S., Jr. ;

Bruggmann, Philip ;

Brunetto, Maurizia R. ;

Busschots, Dana ;

Buti, Maria ;

Butsashvili, Maia ;

Cabezas, Joaquin ;

Chae, Chungman ;

Ivanova, Viktorija Chaloska ;

Chan, Henry Lik Yuen ;

Cheinquer, Hugo ;

Cheng, Kent Jason ;

Cheon, Myeong Eun .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05) :396-415

[5] Elimination of hepatitis C in Australia by 2030: a decade and counting [J].

Dore, Gregory J. .

AUSTRALIAN PRESCRIBER, 2021, 44 (02) :36-37

[6] Pathways to ensure universal and affordable access to hepatitis C treatment [J].

Douglass, Caitlin H. ;

Pedrana, Alisa ;

Lazarus, Jeffrey V. ;

't Hoen, Ellen F. M. ;

Hammad, Radi ;

Leite, Ricardo Baptista ;

Hill, Andrew ;

Hellard, Margaret .

BMC MEDICINE, 2018, 16

[7] Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era [J].

Sacks-Davis, Rachel ;

Doyle, Joseph S. ;

Rauch, Andri ;

Beguelin, Charles ;

Pedrana, Alisa E. ;

Matthews, Gail V. ;

Prins, Maria ;

van der Valk, Marc ;

Klein, Marina B. ;

Saeed, Sahar ;

Lacombe, Karine ;

Chkhartishvili, Nikoloz ;

Altice, Frederick L. ;

Hellard, Margaret E. .

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21

[8] Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response [J].

Simmons, Bryony ;

Saleem, Jawaad ;

Heath, Katherine ;

Cooke, Graham S. ;

Hill, Andrew .

CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) :730-740

[9] Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization [J].

Suthar, Amitabh B. ;

Rutherford, George W. ;

Horvath, Tara ;

Doherty, Meg C. ;

Negussie, Eyerusalem K. .

AIDS, 2014, 28 :S175-S185

[10]

WHO, 2022, License: CC BY-NC-SA 3.0 IGO

← 1 2 →